userfiles/140/my files/powerpoint presentations/social_drugs_nmhs
... Active ingredient: tetrahydrocannabinol (THC) ...
... Active ingredient: tetrahydrocannabinol (THC) ...
Seeds of Doubt - Bruce Goldfarb
... source of illegal drugs. When scored with a knife, the bulb of the poppy flower exudes a thick, milky substance. The liquid turns into a tan, sticky material that is dried and powdered. This material, now called opium, contains several alkaloid compounds used as legal and illegal drugs, including mo ...
... source of illegal drugs. When scored with a knife, the bulb of the poppy flower exudes a thick, milky substance. The liquid turns into a tan, sticky material that is dried and powdered. This material, now called opium, contains several alkaloid compounds used as legal and illegal drugs, including mo ...
fatovich_amphetamine.aspx
... compared with the general population. “In Australia a review of the National Coroners Information System from July 2000 to June 2005 identified 371 amphetamine fatalities.” In the present study four people (2.9%) died within two years of attending the ED with an amphetamine-related presentation. No ...
... compared with the general population. “In Australia a review of the National Coroners Information System from July 2000 to June 2005 identified 371 amphetamine fatalities.” In the present study four people (2.9%) died within two years of attending the ED with an amphetamine-related presentation. No ...
29.5 Brain Function and Chemistry
... feeling of sadness and loss of interest green= low levels of activity ...
... feeling of sadness and loss of interest green= low levels of activity ...
Effect of Gender on Drug Interactions: Metoprolol
... CYP2D6 would not be expected to result in a drug interaction. ...
... CYP2D6 would not be expected to result in a drug interaction. ...
SPC
... A few cases of minor gastrointestinal and neurovegetative disorders have been reported which did not require suspension of treatment. 4.9. OVERDOSAGE Not applicable 5. PHARMACODYNAMIC PROPERTIES 5.1. PHARMACODYNAMIC PROPERTIES Venotonic and vascular protector. - Pharmacology It is active upon the re ...
... A few cases of minor gastrointestinal and neurovegetative disorders have been reported which did not require suspension of treatment. 4.9. OVERDOSAGE Not applicable 5. PHARMACODYNAMIC PROPERTIES 5.1. PHARMACODYNAMIC PROPERTIES Venotonic and vascular protector. - Pharmacology It is active upon the re ...
presentation
... • Usually gives the background and reason the trial is being conducted, but these could be provided in other documents referenced in the protocol (Investigator’s Brochure) • A study plan on which the clinical trial is based • Describes, among other things, what types of people may participate in the ...
... • Usually gives the background and reason the trial is being conducted, but these could be provided in other documents referenced in the protocol (Investigator’s Brochure) • A study plan on which the clinical trial is based • Describes, among other things, what types of people may participate in the ...
Disinfectant
... (3) nucleic acid synthesis, (4) ribosomal function, and (5) metabolite synthesis. 2. Cell wall synthesis is inhibited by ß-lactams, such as penicillins and cephalosporins, which inhibit peptidoglycan polymerization, and by vancomycin, which combines with cell wall substrates. ...
... (3) nucleic acid synthesis, (4) ribosomal function, and (5) metabolite synthesis. 2. Cell wall synthesis is inhibited by ß-lactams, such as penicillins and cephalosporins, which inhibit peptidoglycan polymerization, and by vancomycin, which combines with cell wall substrates. ...
Alterations in Cardiovascular Function:
... •Angiotensin I is a weak vasoconstrictor •Antiotensin II is a very powerful vasoconstrictor •Also, angiotension stimulates release of aldosterone and ADH resulting in increase blood volume (CO) ...
... •Angiotensin I is a weak vasoconstrictor •Antiotensin II is a very powerful vasoconstrictor •Also, angiotension stimulates release of aldosterone and ADH resulting in increase blood volume (CO) ...
Name: Date: ______ 1. All of the following are
... B) lidocaine. C) etomidate. D) procaine. 2. A patient with an allergy to “sulfa” (sulfonamides) should not take A) Augmentin®. B) tetracycline. C) minocycline D) Bactrim DS®. ...
... B) lidocaine. C) etomidate. D) procaine. 2. A patient with an allergy to “sulfa” (sulfonamides) should not take A) Augmentin®. B) tetracycline. C) minocycline D) Bactrim DS®. ...
The Illicit Drug Problem in New Zealand
... were directly attributed to this practice.1 Of the drug users surveyed, about half are estimated to have been current drug users, that is, having used illicit drugs at least once during the past month prior to the date of assessment. It has been estimated that the total number of illicit drug users ...
... were directly attributed to this practice.1 Of the drug users surveyed, about half are estimated to have been current drug users, that is, having used illicit drugs at least once during the past month prior to the date of assessment. It has been estimated that the total number of illicit drug users ...
dhp-chp-presentation-apr-2013
... Emphasis is on reflective learning Supervisor assesses regularly and sign off competencies ...
... Emphasis is on reflective learning Supervisor assesses regularly and sign off competencies ...
Liver Cirrhosis
... how well the liver metabolises drugs Drug metabolism most likely to be impaired when the patient has cirrhosis, and has evidence of coagulation disturbances and low albumin ...
... how well the liver metabolises drugs Drug metabolism most likely to be impaired when the patient has cirrhosis, and has evidence of coagulation disturbances and low albumin ...
Short- and Long-Term Effects and Withdrawal Symptoms
... existing process or state (physiological, psychological or biochemical) can be called a drug. In simpler terms, any chemical that alters the physical or mental functioning of an individual is a drug. A drug may or may not have medical uses; its use may or may not be legal. The use of a drug to cure ...
... existing process or state (physiological, psychological or biochemical) can be called a drug. In simpler terms, any chemical that alters the physical or mental functioning of an individual is a drug. A drug may or may not have medical uses; its use may or may not be legal. The use of a drug to cure ...
Acetazolamide Acetazolamide sodium
... Sulfonamide derivative possessing carbonic anhydrase inhibitor activity. Anticonvulsant effects may be due to (1) inhibition of carbonic anhydrase in the CNS, which increases carbon dioxide tension resulting in a decrease in neuronal conduction, and (2) systemic acidosis. As a diuretic, the drug inh ...
... Sulfonamide derivative possessing carbonic anhydrase inhibitor activity. Anticonvulsant effects may be due to (1) inhibition of carbonic anhydrase in the CNS, which increases carbon dioxide tension resulting in a decrease in neuronal conduction, and (2) systemic acidosis. As a diuretic, the drug inh ...
Level of evidence is given for each drug separately
... Low transfer to breast milk has been shown for infliximab, adalimumab, etanercept and centrolizumab. Continuation of TNF inhibitors should be considered compatible with breast feeding. ...
... Low transfer to breast milk has been shown for infliximab, adalimumab, etanercept and centrolizumab. Continuation of TNF inhibitors should be considered compatible with breast feeding. ...
for the lecture
... 2. Patients forget to take medication, interrupt treatment, cannot afford full course 3. Belief in new medications over old 4. Preferred injections of broad-spectrum drugs 5. Physicians pressured to prescribe antimicrobials 6. Pharmaceuticals marketed directly to public 7. Antibiotics poorly formula ...
... 2. Patients forget to take medication, interrupt treatment, cannot afford full course 3. Belief in new medications over old 4. Preferred injections of broad-spectrum drugs 5. Physicians pressured to prescribe antimicrobials 6. Pharmaceuticals marketed directly to public 7. Antibiotics poorly formula ...
HEMATEMESIS AND GI BLOOD LOSS Michael D Willard
... with esophagitis due to gastroesophageal reflux: these seem to be the main reason for using the PPI’s. The dose of omeprazole is 0.7-1.5 mg/kg qd, although I have often used it at up to 2 mg/kg bid in patients with severe reflux esophagitis or gastrinomas. The dose of lansoprazole (Previcid), pantop ...
... with esophagitis due to gastroesophageal reflux: these seem to be the main reason for using the PPI’s. The dose of omeprazole is 0.7-1.5 mg/kg qd, although I have often used it at up to 2 mg/kg bid in patients with severe reflux esophagitis or gastrinomas. The dose of lansoprazole (Previcid), pantop ...
b.pharm v semister - Andhra University
... 1. Sterilization by autoclaving and test for sterility; 2. Sterilization by dry heat and test for sterility; 3.Sterilization by heating with bactericide and test for sterility; 4. Sterilization by gas and test for sterility; 5. Test for sterility of commercial dextrose injection I.P. 6. Test for ste ...
... 1. Sterilization by autoclaving and test for sterility; 2. Sterilization by dry heat and test for sterility; 3.Sterilization by heating with bactericide and test for sterility; 4. Sterilization by gas and test for sterility; 5. Test for sterility of commercial dextrose injection I.P. 6. Test for ste ...
Computational Biology
... catalyze these reactions, regulate essentially all cellular processes and have thus emerged as therapeutic targets for many human diseases. What are the uses of selective inhibitors? - Small-molecule inhibitors of the Abelson tyrosine kinase and the epidermal growth factor receptor have been develop ...
... catalyze these reactions, regulate essentially all cellular processes and have thus emerged as therapeutic targets for many human diseases. What are the uses of selective inhibitors? - Small-molecule inhibitors of the Abelson tyrosine kinase and the epidermal growth factor receptor have been develop ...
legal highs - Street Aware
... heart palpitations, bladder problems, stomach cramps, circulation problems and changes in behaviour and personality. Some of these drugs have stimulant effects and therefore carry the same risks to those associated with cocaine and amphetamines, including heart problems, fits and seizures. The produ ...
... heart palpitations, bladder problems, stomach cramps, circulation problems and changes in behaviour and personality. Some of these drugs have stimulant effects and therefore carry the same risks to those associated with cocaine and amphetamines, including heart problems, fits and seizures. The produ ...
Drug concentration
... • When HIV reproduces - it makes mistakes - so new virus is not exactly the same • Most of these changes do not matter, but some will stop HIV drugs from working • Resistance only develops when you are taking treatment with a detectable viral load • Main cause of resistance is poor adherence HIV i-B ...
... • When HIV reproduces - it makes mistakes - so new virus is not exactly the same • Most of these changes do not matter, but some will stop HIV drugs from working • Resistance only develops when you are taking treatment with a detectable viral load • Main cause of resistance is poor adherence HIV i-B ...
Cardiovascular system pharmacology
... treatment of choice for rapid reversal. In severe overdose vit.K can be given by I.V injection but this taken 6-12 hrs to act. Agents used for treatment of anemia Anemia is defined as a below-normal plasma hemoglobin concentrations resulting from a decreased number of red blood cells or an abnormall ...
... treatment of choice for rapid reversal. In severe overdose vit.K can be given by I.V injection but this taken 6-12 hrs to act. Agents used for treatment of anemia Anemia is defined as a below-normal plasma hemoglobin concentrations resulting from a decreased number of red blood cells or an abnormall ...
Drug interaction
A drug interaction is a situation in which a substance (usually another drug) affects the activity of a drug when both are administered together. This action can be synergistic (when the drug's effect is increased) or antagonistic (when the drug's effect is decreased) or a new effect can be produced that neither produces on its own. Typically, interactions between drugs come to mind (drug-drug interaction). However, interactions may also exist between drugs and foods (drug-food interactions), as well as drugs and medicinal plants or herbs (drug-plant interactions). People taking antidepressant drugs such as monoamine oxidase inhibitors should not take food containing tyramine as hypertensive crisis may occur (an example of a drug-food interaction). These interactions may occur out of accidental misuse or due to lack of knowledge about the active ingredients involved in the relevant substances.It is therefore easy to see the importance of these pharmacological interactions in the practice of medicine. If a patient is taking two drugs and one of them increases the effect of the other it is possible that an overdose may occur. The interaction of the two drugs may also increase the risk that side effects will occur. On the other hand, if the action of a drug is reduced it may cease to have any therapeutic use because of under dosage. Notwithstanding the above, on occasion these interactions may be sought in order to obtain an improved therapeutic effect. Examples of this include the use of codeine with paracetamol to increase its analgesic effect. Or the combination of clavulanic acid with amoxicillin in order to overcome bacterial resistance to the antibiotic. It should also be remembered that there are interactions that, from a theoretical standpoint, may occur but in clinical practice have no important repercussions.The pharmaceutical interactions that are of special interest to the practice of medicine are primarily those that have negative effects for an organism. The risk that a pharmacological interaction will appear increases as a function of the number of drugs administered to a patient at the same time.It is possible that an interaction will occur between a drug and another substance present in the organism (i.e. foods or alcohol). Or in certain specific situations a drug may even react with itself, such as occurs with dehydration. In other situations, the interaction does not involve any effect on the drug. In certain cases, the presence of a drug in an individual's blood may affect certain types of laboratory analysis (analytical interference).It is also possible for interactions to occur outside an organism before administration of the drugs has taken place. This can occur when two drugs are mixed, for example, in a saline solution prior to intravenous injection. Some classic examples of this type of interaction include that Thiopentone and Suxamethonium should not be placed in the same syringe and same is true for Benzylpenicillin and Heparin. These situations will all be discussed under the same heading due to their conceptual similarity.Drug interactions may be the result of various processes. These processes may include alterations in the pharmacokinetics of the drug, such as alterations in the absorption, distribution, metabolism, and excretion (ADME) of a drug. Alternatively, drug interactions may be the result of the pharmacodynamic properties of the drug, e.g. the co-administration of a receptor antagonist and an agonist for the same receptor.